Related references
Note: Only part of the references are listed.Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience
Keishi Makino et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
A phase 1 dose escalation study of idarubicin combined with methotrexate, vindesine, and prednisolone for untreated elderly patients with primary central nervous system lymphoma: The GOELAMS LCP 99 trial
Gaelle Olivier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Challenges in the treatment of elderly patients with primary central nervous system lymphoma
Patrick Roth et al.
CURRENT OPINION IN NEUROLOGY (2014)
Prognosis Factors in Japanese Elderly Patients with Primary Central Nervous System Lymphoma Treated with a Nonradiation, Intermediate-Dose Methotrexate-Containing Regimen
Suk-young Lee et al.
ONCOLOGY RESEARCH AND TREATMENT (2014)
Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
Patrick G. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)
James L. Rubenstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center
Mary R. Welch et al.
NEURO-ONCOLOGY (2012)
Outcome of elderly patients with primary CNS lymphoma in the G-PCNSL-SG-1 trial
Patrick Roth et al.
NEUROLOGY (2012)
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
K. Fritsch et al.
ANNALS OF ONCOLOGY (2011)
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination
Andres J. M. Ferreri et al.
ONCOLOGIST (2011)
Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)
H. Ghesquieres et al.
ANNALS OF ONCOLOGY (2010)
Primary central nervous system lymphoma in the elderly: a multicentre retrospective analysis
Mascha Schuurmans et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Characteristics and Outcomes of Elderly Patients With Primary Central Nervous System Lymphoma The Memorial Sloan-Kettering Cancer Center Experience
Douglas E. Ney et al.
CANCER (2010)
Treatment approaches for primary CNS lymphomas
Matteo G. Carrabba et al.
EXPERT OPINION ON PHARMACOTHERAPY (2010)
A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma
Kennichi Taoka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
Delia Kurzwelly et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Eckhard Thiel et al.
LANCET ONCOLOGY (2010)
High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study
G. Illerhaus et al.
ANNALS OF ONCOLOGY (2009)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
Andres J. M. Ferreri et al.
LANCET (2009)
Therapeutic challenges in primary CNS lymphoma
Patrick G. Morris et al.
LANCET NEUROLOGY (2009)
High-dose methotrexate for elderly patients with primary CNS lymphoma
Jay-Jiguang Zhu et al.
NEURO-ONCOLOGY (2009)
Primary CNS Lymphoma in Immunocompetent Patients
Monica Sierra del Rio et al.
ONCOLOGIST (2009)
Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy
Meltem Ekenel et al.
CANCER (2008)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
Temozolomide and methotrexate for primary central nervous system lymphoma in the elderly
Antonio M. P. Omuro et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Patterns of treatment in older adults with primary central nervous system lymphoma
Katherine S. Panageas et al.
CANCER (2007)
Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model
Lauren E. Abrey et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan
Keishi Makino et al.
SURGICAL NEUROLOGY (2006)
Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma
Igor T. Gavrilovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Whole-brain radiotherapy and high-dose methylprednisolone for elderly patients with primary central nervous system lymphoma: Results of North Central Cancer Treatment Group (NCCTG) 96-73-51
Nadia N. Laack et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas
AJM Ferreri et al.
NEUROLOGY (2006)
Trends in survival from primary central nervous system lymphoma, 1975-1999 - A population-based analysis
KS Panageas et al.
CANCER (2005)
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
K Jahnke et al.
ANNALS OF ONCOLOGY (2005)
Treatment of primary central nervous system lymphoma in the elderly
K Hoang-Xuan et al.
SEMINARS IN ONCOLOGY (2003)
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: A multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group
K Hoang-Xuan et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: A report of NABTT 96-07
T Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma - A surveillance, epidemiology, and end results analysis
JE Olson et al.
CANCER (2002)
A multicenter study of treatment of primary CNS lymphoma
AJM Ferreri et al.
NEUROLOGY (2002)
German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma
U Herrlinger et al.
ANNALS OF NEUROLOGY (2002)
Current concepts: Toxic leukoencephalopathy.
CM Filley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Treatment for primary CNS lymphoma: The next step
LE Abrey et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
